Delivery Order SPE2DB24D2105-SPE2DB25FAPNK

Award Date 4/25/25
Potential Completion Date 5/16/25
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Promacta 25 mg tablets. The fixed-price, $8,270.72 delivery order contract has an ultimate completion date of December 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $26,508.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the medication Promacta 25 mg tablet, with an ultimate completion date of May 6, 2025. This award is not associated with a set-aside program and is a firm-fixed-price contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,492.89 Firm Fixed Price delivery order is for the drug Promacta 50 mg tablets, with a completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide Promacta 50 mg tablets. The firm-fixed-price delivery order, valued at $14,485.16, has an ultimate completion date of September 24, 2024. The contract is not set aside for any specific business type. AmerisourceBergen is the prime contractor and will supply the medication directly to the DLA, which supports the healthcare needs of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,026.53 fixed-price delivery order is for the supply of PROMACTA 50 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of April 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $8,026.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication PROMACTA 50 MG TABLET UU 30S, with a completion date of May 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $3,360.71 firm fixed-price delivery order is for the pharmaceutical product PROMACTA 50 MG TABLET UU 14S, with a period of performance through May 6, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,418.06 firm fixed-price delivery order is for the supply of 4567796477 PROMACTA 25 MG TABLET UU 30S, with an ultimate completion date of April 24, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,979.02, is for the delivery of Promacta 50 mg tablets. This is a firm fixed-price delivery order with a completion date of November 9, 2022. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the United States. The $3,997.21 firm fixed-price delivery order is for the supply of PROMACTA 25 MG TABLET, a medication used to treat certain blood disorders. This award is a part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
  • SPE2DB24D2105
    Indefinite Delivery Contract
  • SPE2DB24D2105-SPE2DB25FAPNK
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Promacta 25 mg tablets, a medication used to treat certain blood disorders. The contract has a ceiling value of $4,418.06 and is a firm fixed-price delivery order. It does not have a set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/25/25, 11:17 AM